Sterling Capital Management LLC Sells 7,273 Shares of Danaher Corporation $DHR

Sterling Capital Management LLC lessened its holdings in Danaher Corporation (NYSE:DHR) by 8.6% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 77,440 shares of the conglomerate’s stock after selling 7,273 shares during the quarter. Sterling Capital Management LLC’s holdings in Danaher were worth $14,683,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other large investors have also recently made changes to their positions in the company. JPL Wealth Management LLC bought a new stake in shares of Danaher during the 3rd quarter worth $25,000. Elevated Capital Advisors LLC purchased a new stake in Danaher during the fourth quarter worth about $26,000. WFA of San Diego LLC purchased a new stake in Danaher during the second quarter worth about $26,000. Hilton Head Capital Partners LLC bought a new stake in Danaher in the fourth quarter worth about $27,000. Finally, Clal Insurance Enterprises Holdings Ltd boosted its stake in Danaher by 71.6% in the fourth quarter. Clal Insurance Enterprises Holdings Ltd now owns 127 shares of the conglomerate’s stock valued at $29,000 after acquiring an additional 53 shares during the last quarter. 79.05% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

DHR has been the subject of a number of research reports. Weiss Ratings reissued a “hold (c)” rating on shares of Danaher in a research report on Friday, March 27th. Rothschild & Co Redburn set a $205.00 price target on shares of Danaher in a report on Friday, April 17th. Citigroup started coverage on Danaher in a research note on Tuesday, May 26th. They issued a “buy” rating and a $230.00 price objective on the stock. Robert W. Baird decreased their target price on Danaher from $251.00 to $249.00 and set an “outperform” rating for the company in a research report on Friday, April 17th. Finally, Argus lowered their target price on Danaher from $265.00 to $230.00 and set a “buy” rating on the stock in a research note on Friday, April 24th. One research analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating and five have given a Hold rating to the company. According to MarketBeat.com, Danaher has a consensus rating of “Moderate Buy” and an average target price of $233.61.

Danaher Stock Performance

Shares of DHR stock opened at $195.67 on Friday. The firm’s 50 day moving average is $178.81 and its 200 day moving average is $201.69. The stock has a market capitalization of $138.49 billion, a P/E ratio of 37.85, a PEG ratio of 2.46 and a beta of 0.81. Danaher Corporation has a 12 month low of $160.93 and a 12 month high of $242.80. The company has a current ratio of 1.87, a quick ratio of 1.52 and a debt-to-equity ratio of 0.33.

Danaher (NYSE:DHR) last released its quarterly earnings data on Monday, April 20th. The conglomerate reported $2.06 earnings per share for the quarter, beating analysts’ consensus estimates of $1.94 by $0.12. Danaher had a net margin of 14.89% and a return on equity of 10.91%. The business had revenue of $5.95 billion during the quarter, compared to analyst estimates of $6 billion. During the same period in the previous year, the business earned $1.88 EPS. Danaher’s revenue was up 3.7% compared to the same quarter last year. On average, sell-side analysts anticipate that Danaher Corporation will post 8.44 earnings per share for the current year.

Danaher Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Stockholders of record on Friday, June 26th will be given a $0.40 dividend. The ex-dividend date is Friday, June 26th. This represents a $1.60 annualized dividend and a dividend yield of 0.8%. Danaher’s payout ratio is 30.95%.

About Danaher

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.